|
Market Closed -
Bombay S.E.
13:02:27 02/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 6.090 INR | +1.50% |
|
+1.00% | -25.18% |
| Market Cap | 376M 3.96M 3.42M 3.22M 2.93M 5.51M 5.54M 38.01M 14.8M 191M 14.88M 14.56M 634M | P/E 2024 |
-10.3x | P/E 2025 | -13.6x |
|---|---|---|---|---|---|
| Enterprise Value | 443M 4.67M 4.02M 3.79M 3.45M 6.49M 6.52M 44.75M 17.42M 225M 17.52M 17.14M 747M | EV / Sales 2024 |
7.63x | EV / Sales 2025 | 8.85x |
| Free-Float |
22.51% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.50% | ||
| 1 week | +1.00% | ||
| Current month | -2.87% | ||
| 1 month | -7.31% | ||
| 3 months | -19.23% | ||
| 6 months | +5.00% | ||
| Current year | -25.18% |
| 1 week | 5.8 | 6.49 | |
| 1 month | 5.8 | 7.28 | |
| Current year | 5.71 | 8.87 | |
| 1 year | 5.71 | 10.75 | |
| 3 years | 5.71 | 19.7 | |
| 5 years | 5.71 | 19.7 | |
| 10 years | 4.51 | 56.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Murali Meraga
CEO | Chief Executive Officer | - | - |
Suneel Pachipala
DFI | Director of Finance/CFO | - | - |
Barkha Jain
CMP | Compliance Officer | - | 10/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dhananjaya Alli
CHM | Chairman | 76 | 02/01/2014 |
| Director/Board Member | 87 | 16/06/1993 | |
| Director/Board Member | 76 | 02/02/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.50% | +1.00% | -38.92% | -59.15% | 3.89M | ||
| +0.14% | +1.70% | +23.42% | +74.20% | 48.77B | ||
| -1.61% | -0.29% | +51.58% | +118.38% | 40.67B | ||
| -1.16% | +0.37% | +15.87% | +86.01% | 12.27B | ||
| -0.72% | +0.72% | -9.97% | +14.04% | 12.11B | ||
| +0.57% | +1.73% | +31.59% | +153.11% | 9.28B | ||
| -1.75% | -3.23% | +23.87% | +44.12% | 7.55B | ||
| -0.42% | +0.89% | +28.21% | +223.05% | 7.35B | ||
| -0.62% | -0.84% | +44.70% | -11.26% | 7.3B | ||
| -0.13% | -0.16% | -40.47% | +15.85% | 5.25B | ||
| Average | -0.43% | -0.12% | +12.99% | +65.83% | 15.06B | |
| Weighted average by Cap. | -0.65% | +1.25% | +27.28% | +86.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 103M 1.08M 935K 880K 801K 1.51M 1.51M 10.4M 4.05M 52.33M 4.07M 3.98M 174M | 101M 1.06M 916K 861K 785K 1.48M 1.48M 10.18M 3.96M 51.25M 3.99M 3.9M 170M |
| Net income | -45.12M -475K -410K -386K -351K -661K -664K -4.56M -1.78M -22.95M -1.78M -1.75M -76.1M | -46.49M -490K -423K -397K -362K -681K -685K -4.7M -1.83M -23.65M -1.84M -1.8M -78.41M |
| Net Debt | 78.7M 829K 715K 673K 613K 1.15M 1.16M 7.95M 3.1M 40.04M 3.11M 3.05M 133M | 66.71M 703K 606K 570K 520K 977K 982K 6.74M 2.62M 33.93M 2.64M 2.58M 113M |
Employees
30
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | ₹6.090 | +1.50% | 4,905 |
| 01/09/26 | ₹6.000 | -4.31% | 5,939 |
| 31/08/26 | ₹6.270 | -1.10% | 9,143 |
| 28/08/26 | ₹6.340 | +5.32% | 8,559 |
| 27/08/26 | ₹6.020 | -0.17% | 17,294 |
- Stock Market
- Stocks
- VISTAPH6 Stock
Select your edition
All financial news and data tailored to specific country editions
















